Coherus Biosciences reported $-86650000 in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
ALKERMES ALKS:US USD 136K 7.25M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Amarin AMRN:US USD -3883000 60.92M
Amgen AMGN:US USD 2.54B 364M
Baxter International BAX:US USD 547M 2M
Biogen BIIB:US USD 821M 53.8M
Biomarin Pharmaceutical BMRN:US USD -1904000 36.75M
Bluebird Bio BLUE:US USD -76513000 16.99M
Coherus Biosciences CHRS:US USD -86650000 36.5M
Eli Lilly And LLY:US USD 2B 685.3M
Fujifilm 4901:JP JPY 74.34B 19.14B
Horizon Pharma HZNP:US USD 315.1M 27.58M
JAZZ PHA JAZZ:US USD 417.37M 71.06M
Merk MRK:US USD 5.45B 57M
Myriad Genetics MYGN:US USD -19800000 19.5M
Perrigo Ordinary Shares PRGO:US USD 96.7M 19.3M
Pfizer PFE:US USD 7.38B 3.3B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Revance Therapeutics RVNC:US USD -83993000 22.56M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Teva Pharmaceutical TEVA:IT USD 768M 1.93B
Xencor XNCR:US USD -31671000 2.3M